Independent Pharmaceutica aims to provide
pharmacological solutions for treatment of nicotine addiction. The company
is spun out of research from the Karolinska Institutet in Stockholm, Sweden.
Tobacco use is the leading preventable
cause of morbidity and premature death in the world. Currently over 1.2
billion people smoke worldwide and the number of annual deaths from tobacco-related
diseases is over 4 million and rising. The costs for society are huge.
With the new vaccine Niccine® against
nicotine addiction, the health condition of millions of patients is expected
to be improved.